LumaWave wins Tulane Innovation Institute's Open Season
CEO Dr. Vinoin Devpaul Vincely places first at Tulane's Open Season presenting LumaWave's photoacoustic technology for continous fetal oximetery.
Read This ArticleRead more about LumaWave's recent updates!
CEO Dr. Vinoin Devpaul Vincely places first at Tulane's Open Season presenting LumaWave's photoacoustic technology for continous fetal oximetery.
Read This ArticleWe are happy to announce our most recent publication in Biomedical Optics Express. This validation of our technical approach is an exciting new development for LumaWave.
Read This ArticleLumaWave was featured in an article by Tulane's Innovation Institute, highlighting the team's progress in developing portable photoacoustic imaging technology. The feature showcases how the team is leveraging the NSF I-Corps program to evaluate clinical needs and market potential, underscoring LumaWave's commitment to advancing accessible diagnostic tools for vascular health.
Read This ArticleCEO Dr. Vinoin Devpaul Vincely wins Tulane's 5th Open Medical Innovation Challenge presenting LumaWave's point-of-care photoacoustic imaging device aimed at the early detection of peripheral artery disease (PAD).
Read This ArticleLumaWave's team was awarded the Tulane PPOC fund to develop a proof of concept prototype of a low-cost, point-of-care photoacoustic imaging prototype for assessment of tissue ischemia. The award marks a key milestone in translating fundamental research from the Bayer Lab into a viable clinical solution.
Read This Article